Vrtx stock forecast.

Dec 1, 2023 · 19 brokers have issued 12-month price targets for Vertex Pharmaceuticals' shares. Their VRTX share price targets range from $296.00 to $456.00. On average, they expect the company's stock price to reach $376.13 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View analysts price targets for VRTX or view ... Dec 1, 2023 · Vertex Pharmaceuticals last posted its quarterly earnings data on November 6th, 2023. The pharmaceutical company reported $4.08 earnings per share for the quarter, beating analysts' consensus estimates of $3.53 by $0.55. The company had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.50 billion. Nov 28, 2023 · See the latest Vortex Energy Corp Ordinary Shares stock price (VTECF:PINX), related news, valuation, dividends and more to help you make your investing decisions. VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.95.34. -1.33%. 1.33M. Find the latest Vortex Energy Corp (VRTX) stock forecast, 12-month price target, predictions and analyst recommendations.

VRTX Stock Forecast! 7% Yield Trading Last 12 Weeks. Hey everyone! In this item, I will briefly show how our algorithm has been trading VRTX (Vertex Pharmaceuticals) stock in a one-week timeframe timeframe over the last 12 weeks, and how it has performed during that period. The algorithm has been designed to trade in a way that is similar…Nov 29, 2023 · Vertex Pharmaceuticals (VRTX) Quote Overview » More Research » Vertex Pharmaceuticals (VRTX) Full Company Report Better trading starts here. Company Summary

In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Mar 4, 2023 · I think that Vertex Pharmaceuticals (VRTX-0.05%) is another S&P 500 stock with a clear path to doubling or more by 2030. The company already enjoys a monopoly in treating the underlying cause of ...

23 oct 2023 ... Stock Price data may be delayed up to 15 minutes. Copyright © 2023. Portions of this content may be copyrighted by Fresh Brewed Media, Investors ...14,273.23 +47.02(+0.33%) Russell 2000 1,848.29 +39.27(+2.17%) Crude Oil 76.33 +0.37(+0.49%) Gold 2,077.30 +20.10(+0.98%) Advertisement Vertex Pharmaceuticals Incorporated (VRTX) NasdaqGS -...Find real-time VREX - Varex Imaging Corp stock quotes, company profile, news and forecasts from CNN Business.Find the latest Vertex Pharmaceuticals Incorpor VRTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment rating...

Based on analysts offering 12 month price targets for VRTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

The stock price has ranged from a 52-week low of $233.01 to a 52-week high of $325.19. Vertex closed on March 17, 2023, at $295.77. That gave it a PE (price to earnings ratio, forward) of near 20 ...

VRTX 1.03%. Vertiv Holdings Co. $45.14. VRT 3.39%. Vista Outdoor Inc. $28.52. VSTO 1.10%. Voice Assist Inc ... A valuation method that multiplies the price of a company's stock by the total number ... Vertex Pharmaceutic stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction. ... VRTX Related stocks. Symbol 3M %Chg ; VRTX +3.45% : Vertex Pharmaceutic: AMGN ...MFA Financial (NYSE:MFA) pays an annual dividend of $1.40 per share and currently has a dividend yield of 13.33%. MFA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read …Find real-time NEP - Nextera Energy Partners LP stock quotes, company profile, news and forecasts from CNN Business.Vertex Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VRTX updated stock price target summary.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

20 Ratings 14 Buy 6 Hold 0 Sell Based on 20 analysts giving stock ratings to Vertex Pharmaceuticals in the past 3 months VRTX Stock 12 Months Forecast $392.58 (5.07% …Next on this list of biotech stocks to buy is Vertex Pharmaceuticals (NASDAQ: VRTX).The biotech giant is an undisputed leader in cystic fibrosis treatments. On April 26, 2023, the company received ...May 2, 2023 · On today's stock market, VRTX stock rose 0.3% to close at 346.03. Vertex is the leading maker of cystic fibrosis treatments. Product sales climbed 13% to $2.37 billion and beat forecasts for $2.34 ... VRTX Stock 12 Months Forecast. Based on 20 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $392.58 with a high forecast of $456.00 and a low forecast of $325.00. The average price target represents a 5.07% change from the last price of $373.65.Get real-time Vertex Pharmaceuticals (VRTX) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and ...

Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report Editas Medicine, Inc. (EDIT) : Free Stock Analysis Report CytomX Therapeutics, Inc. (CTMX) : Free Stock Analysis Report

Based on short-term price targets offered by 23 analysts, the average price target for Vertex Pharmaceuticals comes to $392.65. The forecasts range from a low of $315.00 to a high of $456.00.Analyst Forecast. According to 27 analysts, the average rating for VRTX stock is "Buy." The 12-month stock price forecast is $372.96, which is an increase of …Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $89.75B. +20.9%. Market Cap / Employee. The market cap of a ...Vertex Pharmaceuticals (VRTX) closed at $308.40 in the latest trading session, marking a -1.18% move from the prior day. This move was narrower than the S&P 500's daily loss of 2.49%.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.VRTX Stock Forecast: Will We See $400 this Year in (NASDAQ: VRTX)? 1 Vertex stock price is above the dominant upward trendline with a year-to-date return of 21.11% & the three-month return is +0.80% 2 Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) stock’s 52-week pric...Price, $355.84. Change, +1.03 (+0.29%). 12/01/2023 - 09:59 AM EST. Data Provided by Refinitiv. Delayed ~15m. Nasdaq: VRTX. Vertex Pharmaceuticals. Stock ...Future criteria checks 2/6. Vertex Pharmaceuticals is forecast to grow earnings and revenue by 10.4% and 8% per annum respectively. EPS is expected to grow by 10.2% per annum. Return on equity is forecast to be 32.8% in 3 years.13 equities research analysts have issued 12-month price targets for Fifth Third Bancorp's shares. Their FITB share price targets range from $28.00 to $37.00. On average, they predict the company's share price to reach $32.03 in the next year. This suggests a possible upside of 12.7% from the stock's current price.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.

Next reporting date: January 31, 2024: EPS forecast (this quarter) $3.76: Annual revenue (last year) $8.7B: Annual profit (last year) $3.3B: Net profit margin

Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 2.65, with a high estimate of 12.35 and a low estimate of 1.25. The median ...

A glance at the 2Q results. VRTX's quarterly revenue totaled $2.49 billion (+14% YoY, +5% QoQ), 3% better than the consensus expected. Non-US YoY revenue growth rate was at 26%, while US revenue ...The 27 analysts offering 1 year price forecasts for VRTX have a max estimate of — and a min estimate of —. Analyst rating Based on 31 analysts giving stock ratings to VRTX in the past 3 months.Their MAIN share price targets range from $40.00 to $47.00. On average, they anticipate the company's share price to reach $43.20 in the next twelve months. This suggests a possible upside of 4.7% from the stock's current price. View analysts price targets for MAIN or view top-rated stocks among Wall Street analysts.Vertex Pharmaceuticals last posted its quarterly earnings data on November 6th, 2023. The pharmaceutical company reported $4.08 earnings per share for the quarter, beating analysts' consensus estimates of $3.53 by $0.55. The company had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.50 billion.RJF Stock 12 Months Forecast. Based on 8 Wall Street analysts offering 12 month price targets for Raymond James Financial in the last 3 months. The average price target is $110.86 with a high forecast of $118.00 and a low forecast of $100.00. The average price target represents a 7.40% change from the last price of $103.22.Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Vertex Pharmaceuticals (VRTX) will release its next earnings report on Jan 31, 2024. In the last quarter Vertex Pharmaceuticals reported $3.917 EPS in relation to $4.08 expected by the market.Mar 13, 2023 · Here are three stocks that I think will be in the Dow by 2030. 1. Alphabet. Alphabet ( GOOG -1.29%) ( GOOGL -1.30%) is the only stock with a market cap of over $1 trillion that isn't in the Dow ... Vertex Pharmaceuticals last posted its quarterly earnings data on November 6th, 2023. The pharmaceutical company reported $4.08 earnings per share for the quarter, beating analysts' consensus estimates of $3.53 by $0.55. The company had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.50 billion.Based on analysts offering 12 month price targets for VRTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Vertex Pharmaceuticals Inc. research and ratings by Barron's. View VRTX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.On May 17, 2023, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock closed at $341.20 per share. One-month return of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was 3.66%, and its ...Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Vertex ( VRTX ): VRTX is a leader in the cystic fibrosis market and looks ready to get a big boost from a Sickle Cell Disease treatment. Buy now is the signal for these three biotech stocks as the ...Instagram:https://instagram. can you trade options in an irasave stock forecasttrade desk stock forecast 2025sure dividend Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, cash flow, balance sheet, and market outlook for the next quarter and year. how to buy carnival cruise stockday trade course The 38 Wall Street analysts offering Vertex Pharmaceuticals Incorporated stock forecast in the last 6 months have average price target of $370.24 with a high forecast of $456.0 and a low forecast of $245.0. The average Vertex Pharmaceuticals Incorporated stock forecast represents a 4.36% increase from the last price of $354.779998779297.23 oct 2023 ... Stock Price data may be delayed up to 15 minutes. Copyright © 2023. Portions of this content may be copyrighted by Fresh Brewed Media, Investors ... volkswagen stocks Nov 14, 2023 · Find the latest Vertex Pharmaceuticals Incorpor (VRTX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance On today's stock market, VRTX stock advanced 9% to 313.89. ... VRTX stock analysts forecast adjusted profit of $14.14 per share and $8.79 billion in sales.Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...